6MWT对慢性心力衰竭患者心功能的评估价值被引量：3

下载PDF

导出

摘要目的:评价6 min步行法(6MWT)在慢性心力衰竭(CHF)中的应用以及6 min步行距离与其他心力衰竭指标之间的相关性并指导干预治疗。方法:对20例正常患者(对照组)与80例CHF患者(观察组)的6 min步行距离、纽约心功能分级(NYHA)、左室射血分数(EF)、B型利钠肽(BNP)进行比较。结果:两组患者步行距离有较大差异(P<0.05),观察组NYHAⅡ、Ⅲ、Ⅳ级患者中的步行距离有有较大差异(P<0.05),6MWT与BNP具有较好的相关性。结论:6MWT与心力衰竭患者的NYHA有正相关性,可以与其他临床常用的可以反映心功能的指标联合使用,以提高临床判断心功能程度的准确性,是一种客观检测法。

作者李红霞

机构地区广州市花都区第二人民医院

出处《深圳中西医结合杂志》 2016年第8期128-129,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine

关键词 6 MIN步行试验慢性心力衰竭心功能评估

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献6

1Guyatt GH,Sullivan MJ,Thompson PJ,et al.The 6-minute walk:a new measure of exercise capcity in patients with chronic heart failure /J/ .Can MedAssoc J,1985,132(8):919-923.
2惠海鹏,许顶立,刘伊丽.慢性心力衰竭患者的运动实验和运动训练[J].中国循环杂志,2000,15(6):380-381. 被引量：24
3慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量：2413
4赵丽,吴学思,韩智红,胡荣,吕强.B型利钠肽检测对心力衰竭患者的临床评估[J].中华心血管病杂志,2004,32(1):51-52. 被引量：164
5Luchner A,Stevens TL,Borgeson DD,et al.Diferential atria and ventricular expression of myocardial BNP during evalution of heart failure I J) .Am J Physiol,1998,274(5 Pt 2):1684-1689.
6Maeda K,Tsutamoto T,Wada A,et.al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction I J) .Am Heart J,1998,135(5 Pt 1):825-832.

二级参考文献30

11，Heart Failure Consensus Recommendat-ions Committee.Consensu recommendati-ons for heart Failure.Am J Cardiol,1999,83:1A—38A.
22，Franisoa JA.Exercise testing in chronic heart failure.Am J Cardiol,1984,53:1447—1451.
33，Swedberg K,Gandersen T.The role of exercise testing in heart failure.J Cardiovasc Pharmacol,1993,22:S13—S17.
44，Weber KT,Janicki JS.Anaerobic thresh-old and aerobic capaity in the evaluation of chronic cardiac or circulatory failure.Advances in Cardiology,1986,35:79—87.
55，Jondeau G,Katz SD,Zohman L,et al.Active skeletal muscle mass and cardiopulmonary reserve:Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure.Circulation,1992,86:1351—1356.
66，Myer J,Gullestad L,Vagelos K,et al.Clinical hemodynamic and cardiopulmonary exercise test:determinants of surivao in patients referred for evaluation of heart failure.Ann Inter Med,1998,129:286—293.
77，Schaufelberger M,Swecberg K,Goteborg S.Is 6-mintue walk test of value in congestive heart failure?Am Heart J,1998,136:371—372.
88，Gualeni A,D'Alola A,Gintilini A,et al.Effects of maximally tolerated oral therapy on the six-minute walking test in patients with chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.Am J Cardiol,1998,81:1370—1372.
99，Roul G,Germain P,Bareiss P,et al.Dose the 6-minute walk test predict the prognosis in patients with NYHA class Ⅱ or Ⅲ chronic heart failure? Am Heart J,1998,136:449—457.
1010，Bittner V,Weiner D,Yusuf S,et al.Pred-iction of mortality and morbidity with 6-minute walk test in patients with left ventricular dysfuntion.JAMA,1993,270:1702—1707.